EcoDrugPlus

Ensembl ID : ENSOMYG00000028393
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSOMYG00000013147
Gene Symbol: -
Cross references: -
288 Possible Orthologues:

Ensembl ID : ENSOMYG00000027532
Gene Symbol: -
Cross references: -
130 Possible Orthologues:

Ensembl ID : ENSOMYG00000011383
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSOMYG00000027791
Gene Symbol: -
Cross references: -
129 Possible Orthologues:

Ensembl ID : ENSOMYG00000027797
Gene Symbol: -
Cross references: -
269 Possible Orthologues:

Ensembl ID : ENSOMYG00000027818
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSOMYG00000027945
Gene Symbol: -
Cross references: -
518 Possible Orthologues:

Ensembl ID : ENSOMYG00000000193
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSOMYG00000028563
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSOMYG00000028613
Gene Symbol: -
Cross references: -
133 Possible Orthologues:

Ensembl ID : ENSOMYG00000029100
Gene Symbol: -
Cross references: -
185 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).